Literature DB >> 1940323

Image cytometry of progesterone receptor expression during the cell cycle in the MCF-7 cell line.

S Cassanelli1, P Guillaud, J Louis, D Seigneurin.   

Abstract

Progesterone receptors (PR) appear to be distributed in a heterogeneous way in mammary tumor cells. The study presented here was designed to examine if heterogeneity of PR expression is cell-cycle dependent. Immunofluorescence techniques were used to label PR on the MCF-7 human breast cancer cell line and image cytometry was used to analyze the PR expression during G0 (Ki-67 antigen-negative cells), G1, S, and G2/M cell-cycle phases. A second PR, BrdU, and DNA analysis was performed to study PR expression in the S-phase (BrdU-positive cells). Our results show that PR synthesis occurs preferentially during the G0-G1 transition and that PR levels are constant during the G1-G2 transition. The PR expression appears to be cell-cycle related and may therefore explain the heterogeneity of PR expression. However, the possibility that PR heterogeneity may be linked to the existence of PR-negative subclones cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940323     DOI: 10.1177/39.12.1940323

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  4 in total

1.  An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Authors:  M Finsterbusch; V Khare; C Campregher; R Evstatiev; C Gasche
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

2.  Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo.

Authors:  P Rostagno; J L Moll; I Birtwisle-Peyrottes; F Ettore; C Caldani
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens.

Authors:  P Rostagno; C Caldani; B Lahlou
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.

Authors:  Tonatiuh Barrios-García; Vania Gómez-Romero; Ángeles Tecalco-Cruz; Viviana Valadéz-Graham; Alfonso León-Del-Río
Journal:  Mol Genet Metab Rep       Date:  2016-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.